Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: A preliminary study

  • V. Ricca
  • E. Mannucci
  • A. Paionni
  • M. Di Bernardo
  • M. Cellini
  • P. L. Cabras
  • C. M. Rotella
Brief Report

Abstract

The efficacy of venlafaxine and fluoxetine in the treatment of atypical anorexia nervosa (AN) was compared in a controlled trial. A consecutive series of 24 atypical anorectic females was assigned to either venlafaxine (75 mg/day) or fluoxetine (40 mg/day) plus cognitive-behavioural therapy (CBT). Eating Disorder Examination (EDE12.0D), Beck Depression Inventory (BDI) and State and Trait Anxiety Inventory (STAI) scores were compared before and after 6 months of treatment. Venlafaxine and fluoxetine determined an increase of body mass index (BMI) and a significant reduction of EDE12.0D and BDI scores venlafaxine alone reduced STAI scores. It would seem that venlafaxine is as effective as fluoxetine when combined with CBT in the treatment of atypical AN.

Key words

Venlafaxine fluoxetine atypical anorexia nervosa cognitive-behavioural therapy psychiatric comorbidity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bunnel D.W., Shenker I.R., Nussbaum N.T., Jacobson M.S., Cooper P.: Subclinical versus formal eating disorders: Differentiating psychological features. Int. J. Eating Disord., 9, 357–362, 1990.CrossRefGoogle Scholar
  2. 2.
    Herzog D.B., Hopkins J.D., Bums C.D.: A follow-up study of 33 subdiagnostic cating disordered women. Int. J. Eating Disord., 14, 261–267, 1993.CrossRefGoogle Scholar
  3. 3.
    American Psychiatry Association: Diagnostic and statistical manual of mental disorders, 3th ed., revised. Washington DC., A.P.A. Press, 1987.Google Scholar
  4. 4.
    American Psychiatry Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Washington DC., A.P.A. Press, 1994.Google Scholar
  5. 5.
    Dancyger I.F., Garfinkel P.E.: The relationship of partial syndrome eating disorders to anorexia nervosa and bulimia nervosa. Psychol. Med., 25, 1019–1025, 1995.CrossRefPubMedGoogle Scholar
  6. 6.
    Cotrufo P., Barretta V., Monteleone P., Maj M.: Full-syndrome, partial-syndrome and subclinical eating disorders: an epidemiological study of female students in Southern Italy. Acta Psychiatr. Scand., 98, 112–115, 1998.CrossRefPubMedGoogle Scholar
  7. 7.
    Shisslak C.M., Crago M., Yates A.: Typical pattems in atypical anorexia nervosa. Psychosomatics 30, 307–311, 1989.CrossRefPubMedGoogle Scholar
  8. 8.
    Mitrany E.: Atypical eating disorders. J. Adolesc. Health, 13, 400–402, 1992.CrossRefPubMedGoogle Scholar
  9. 9.
    Walters E.E., Kendler K.S.: Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am. J. Psychiatry, 152, 64–71, 1995.CrossRefPubMedGoogle Scholar
  10. 10.
    Walsh B.T., Devlin M.J.: The pharmachological treatment of eating disorders. In: Shaffer D. (Ed.) Psychiatric clinics of North America. Philadelphia, WB Saunders, 1992, pp. 149–160.Google Scholar
  11. 11.
    Wood A.: Pharmacotherapy of bulimia nervosa-experience with fluoxetine. Int. Clin. Psychopharmacol., 8, 295–299, 1993.CrossRefPubMedGoogle Scholar
  12. 12.
    Kaye W.H., Weltzin T.E., Hsu G., et al.: Relapse prevention with fluoxetine in anorexia nervosa: a double-blind placebocontrolled study. In: New Research program and abstracts of the 150th annual meeting of the AM Psych. Association, May 21, 1997, San Diego, CA. (abstract no. 405: 178).Google Scholar
  13. 13.
    Joffe R.T., Marshall A.M., Lee D.K.: A large open-label study of venlafaxine in depressed outpatients by community-based physicians. J. Clin. Psychol., 59, 515–520, 1999.Google Scholar
  14. 14.
    Ravindran A.V., Charbonneau Y., Zaharia M.D., et al.: Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia. J. Psychiatry Neurosci., 23, 288–292, 1998.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Costa S., Silva J.: Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression. J. Clin. Psychol., 59, 352–357, 1998.Google Scholar
  16. 16.
    Garner D.M., Bemis K.M.: Cognitive therapy for anorexia nervosa. In: Garner D.M., Garfinkel P.E. (Eds.) Handbook of psychotherapy for anorexia nervosa and bulimia. New York, Guilford Press, 1984, pp. 107–146.Google Scholar
  17. 17.
    Fairburn C.G., Cooper Z.: The eating disorder examination, 12th ed. In: Fairburn C.G., Wilson G.T. (Eds.) Binge eating: Nature, assessment and treatment. New York, Guilford Press, 1993, pp. 317–360.Google Scholar
  18. 18.
    Mannucci E., Ricca V., Di Bernardo M., Rotella C.M.: Studio del comportamento alimentare con una intervista strutturata: la Eating Disorder Examination. Il Diabete, 8, 127–131, 1996.Google Scholar
  19. 19.
    Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J.: An inventory for measuring depression. Arch. Gen. Psychiatry, 5, 561–571, 1961.CrossRefGoogle Scholar
  20. 20.
    Spielberg C.D., Gorsuch R.L., Lushene R.E.: Manual for the state trait anxiety inventory (self evaluation questionnaire). Palo Alto, CA, Consulting Psychologists Press, 1970.Google Scholar
  21. 21.
    Garattini S., Bizzi A., Caccia S., et al.: Progress in assessing the role of serotonin in the controi of food intake. Clin. Neuropharmacol. 11 (Suppl. 1), S8–S32, 1988.PubMedGoogle Scholar
  22. 22.
    Kishchuk N., Gagnon G., Belisle D., Laurendau M.C.: Sociodemographic and psychological correlates of actual and desired weight insufficiency in general population. Int. J. Eating Disord., 12, 73–81, 1992.CrossRefGoogle Scholar

Copyright information

© Editrice Kurtis 1999

Authors and Affiliations

  • V. Ricca
    • 1
  • E. Mannucci
    • 2
  • A. Paionni
    • 1
  • M. Di Bernardo
    • 1
  • M. Cellini
    • 1
  • P. L. Cabras
    • 1
  • C. M. Rotella
    • 2
  1. 1.Psychiatric Unit, Department of Neurologic and Psychiatric SciencesUniversity of FirenzeItaly
  2. 2.Section of Metabolic Diseases and Diabetology, Unit of Endocrinology Department of Clinical PathophysiologyUniversity of FirenzeFirenzeItaly

Personalised recommendations